全文获取类型
收费全文 | 192086篇 |
免费 | 7903篇 |
国内免费 | 379篇 |
专业分类
耳鼻咽喉 | 3388篇 |
儿科学 | 6994篇 |
妇产科学 | 4780篇 |
基础医学 | 27225篇 |
口腔科学 | 5071篇 |
临床医学 | 14810篇 |
内科学 | 35664篇 |
皮肤病学 | 5209篇 |
神经病学 | 17912篇 |
特种医学 | 9551篇 |
外国民族医学 | 26篇 |
外科学 | 31225篇 |
综合类 | 1291篇 |
一般理论 | 42篇 |
预防医学 | 9482篇 |
眼科学 | 4861篇 |
药学 | 13293篇 |
中国医学 | 392篇 |
肿瘤学 | 9152篇 |
出版年
2023年 | 851篇 |
2021年 | 1546篇 |
2020年 | 1307篇 |
2019年 | 1557篇 |
2018年 | 3420篇 |
2017年 | 2736篇 |
2016年 | 3768篇 |
2015年 | 4194篇 |
2014年 | 4374篇 |
2013年 | 6247篇 |
2012年 | 9797篇 |
2011年 | 9308篇 |
2010年 | 5320篇 |
2009年 | 4302篇 |
2008年 | 8893篇 |
2007年 | 9826篇 |
2006年 | 9849篇 |
2005年 | 10141篇 |
2004年 | 9663篇 |
2003年 | 9416篇 |
2002年 | 9329篇 |
2001年 | 6631篇 |
2000年 | 6689篇 |
1999年 | 5850篇 |
1998年 | 1753篇 |
1997年 | 1430篇 |
1996年 | 1099篇 |
1995年 | 930篇 |
1994年 | 862篇 |
1992年 | 2613篇 |
1991年 | 2549篇 |
1990年 | 2469篇 |
1989年 | 2321篇 |
1988年 | 2029篇 |
1987年 | 2024篇 |
1986年 | 1883篇 |
1985年 | 1826篇 |
1984年 | 1413篇 |
1983年 | 1162篇 |
1979年 | 1491篇 |
1978年 | 1103篇 |
1977年 | 931篇 |
1975年 | 1192篇 |
1974年 | 1210篇 |
1973年 | 1110篇 |
1972年 | 1118篇 |
1971年 | 1079篇 |
1970年 | 957篇 |
1969年 | 895篇 |
1968年 | 879篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
Increased arterial stiffness in young normotensive patients with Turner syndrome: associations with vascular biomarkers 下载免费PDF全文
13.
More than just crushing: a prospective pre‐post intervention study to reduce drug preparation errors in patients with feeding tubes 下载免费PDF全文
14.
15.
16.
L. Misery E. Weisshaar E. Brenaut A.W.M. Evers F. Huet S. Ständer A. Reich E. Berardesca E. Serra-Baldrich J. Wallengren D. Linder J.W. Fluhr J.C. Szepietowski H. Maibach for the Special Interest Group on sensitive skin of the International Forum for the Study of Itch 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):222-229
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin – as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin. 相似文献
17.
18.
Femoral access‐related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure 下载免费PDF全文
19.
Ouédraogo Dieu-Donné Tiendrébéogo Wendlassida Joelle Stéphanie Kaboré Fulgence Ntsiba Honoré 《Clinical rheumatology》2020,39(7):2069-2075
Clinical Rheumatology - Since December 2019, the pandemic caused by coronavirus disease 2019 (COVID-19) raises a real public health problem. COVID-19 appeared in Wuhan (Hubei province) in China.... 相似文献
20.
Raphael Mohr Robert Schierwagen Carolynne Schwarze-Zander Christoph Boesecke Jan-Christian Wasmuth Jonel Trebicka Jürgen Kurt Rockstroh 《Medicine》2015,94(50)
Liver-related death in human immunodeficiency virus (HIV)-infected individuals is about 10 times higher compared with the general population, and the prevalence of significant liver fibrosis in those with HIV approaches 15%. The present study aimed to assess risk factors for development of hepatic fibrosis in HIV patients receiving a modern combination anti-retroviral therapy (cART).This cross-sectional prospective study included 432 HIV patients, of which 68 (16%) patients were anti-hepatitis C virus (HCV) positive and 23 (5%) were HBsAg positive.Health trajectory including clinical characteristics and liver fibrosis stage assessed by transient elastography were collected at inclusion. Liver stiffness values >7.1 kPa were considered as significant fibrosis, while values >12.5 kPa were defined as severe fibrosis. Logistic regression and Cox regression uni- and multivariate analyses were performed to identify independent factors associated with liver fibrosis.Significant liver fibrosis was detected in 10% of HIV mono-infected, in 37% of HCV co-infected patients, and in 18% of hepatitis B virus co-infected patients. The presence of diabetes mellitus (odds ratio [OR] = 4.6) and FIB4 score (OR = 2.4) were independently associated with presence of significant fibrosis in the whole cohort. Similarly, diabetes mellitus (OR = 5.4), adiposity (OR = 4.6), and the FIB4 score (OR = 3.3) were independently associated with significant fibrosis in HIV mono-infected patients. Importantly, cumulative cART duration protected, whereas persistent HIV viral replication promoted the development of significant liver fibrosis along the duration of HIV infection.Our findings strongly indicate that besides known risk factors like metabolic disorders, HIV may also have a direct effect on fibrogenesis. Successful cART leading to complete suppression of HIV replication might protect from development of liver fibrosis. 相似文献